2013-01-14 01:23:20 - Reimbursement in Europe and Indication-Specific Pricing - a new market research report on companiesandmarkets.com

When seeking a higher price for an additional indication, in an ideal case, the product will offer superior clinical and economic value, the additional indication will have a small, geographically concentrated population, and the product will be delivered in specialized clinics or hospitals only.

Barriers to dual pricing may include regulatory issues, and lack of differentiation at supply chain and prescriber levels.

Germany, the UK, and France among others are changing pricing and reimbursement systems, in efforts to contain healthcare spending. Most notably, free pricing in Germany is to become much more constrained.

This report sets out pricing and reimbursement mechanisms across the major European markets, tracking the increasing importance of health technology assessments. The final chapter develops scenarios for setting a higher

 

 

price in a subsequently approved indication, highlighting the key determinants of success.

Report Scope

- Understand the key determinants of success in gaining a higher price in a subsequent indication.
- Assess pricing and reimbursement systems in major European markets.
- Evaluate developments to pricing and market access systems in the UK, Germany, France, Italy, and Spain.
- Develop an understanding of how payers value pharmaceutical products.
- Learn how international price referencing is being applied across EU markets.

Reasons To Buy

- What changes are occurring in pricing and reimbursement in major markets?
- Which key stakeholders control the pricing and market access systems in major markets?
- What are the potential barriers to dual pricing initiatives?
- How can drug developers deal with value-assessment and pricing methodologies in major markets?
- What factors need to be considered when seeking a higher price in an additional approved indication?

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.